Download Gene Section PPP2R4 (protein phosphatase 2A activator, regulatory subunit 4)

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Gene Section
Mini Review
PPP2R4 (protein phosphatase 2A activator,
regulatory subunit 4)
Veerle Janssens
Protein Phosphorylation and Proteomics Group, Department of Molecular Cell Biology, Faculty of
Medicine, University of Leuven, Campus GHB O&N1, Herestraat 49, box 901, B-3000 Leuven, Belgium
(VJ)
Published in Atlas Database: February 2009
Online updated version: http://AtlasGeneticsOncology.org/Genes/PPP2R4ID41817ch9q34.html
DOI: 10.4267/2042/44661
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2010 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Identity
(dolichyl pyrophosphate phosphatase 1), CRAT
(carnitine acetyltransferase), PPP2R4,
IER5L (immediate early response 5-like), C9orf106.
Note
In fact the gene name would be better: 'protein
phosphatase 2A, regulatory subunit 4' or 'protein
phosphatase 2A activator', and not a mixture of the two.
Other names: MGC2184; OTTHUMP00000022333;
PP2A; PR53; PTPA
HGNC (Hugo): PPP2R4
Location: 9q34.11
Local order: From centromere to telomere: DOLPP1
DNA/RNA
Figure 1. Schematic representation of PPP2R4 splice variants
The top line represents the PPP2R4 gene. Exons are boxed (5' and 3' UTR are speckled). Introns and the 3' UTR are not drawn to scale.
PTPA alpha and beta are the major transcripts/proteins; PTPA gamma, zeta and eta do not encode functional proteins and probably
result from splicing errors. Gene promoter has been analyzed and resides in a non-methylated CpG island. No TATA or CAAT box. Two
functional yin-yang-1 (YY1) binding sites direct basal promoter expression. Tumor suppressor p53 represses transcription through a
mechanism involving YY1 inhibition
Atlas Genet Cytogenet Oncol Haematol. 2010; 14(1)
48
PPP2R4 (protein phosphatase 2A activator, regulatory subunit 4)
Janssens V
Figure 2. Schematic structure of the PPP2R4 promoter
Two YY1 sites are required for basal PPP2R4 promoter activity and reside within the minimal promoter (nt -67/+38 relative to the start of
transcription which is at +1). Upstream of this minimal promoter a GC-rich Sp1-cluster is present (nt -670/-470) of which the functionality
has not yet been proven. The PPP2R4 promoter resides within an unmethylated CpG island.
Description
Function
The gene encompasses around 40 kb; 11 exons.
Stimulates the phosphotyrosyl phosphatase activity
of the PP2A core heterodimer in the presence of
ATP/Mg2+ (in vitro).
Reactivates the phosphoserine/threonine phospha-tase
activity of an inactive PP2A form in the presence of
ATP/Mg2+. This inactive PP2A is associated with the
PP2A methylesterase (PME-1).
peptidyl
prolyl
cis/trans
ATP/Mg2+-dependent
isomerase acting on Pro190 in the PP2A catalytic
subunit.
Binds to the PP2A heterodimeric core enzyme (A and
C subunit).
Required for the biogenesis of active PP2A.
Reported to be pro- as well as anti-apoptotic.
In Saccharomyces cerevisiae: two orthologues found.
Involved in protection against oxidative damage, G1
progression, G2/M transition, Target of Rapamycin
(TOR) pathway.
Transcription
Several transcripts have been identified, resulting from
alternative splicing; two transcripts in Northern blot of
human placental RNA with probe encompassing exons
1-10: 4.1 kb and 2.8 kb (likely resulting from the use of
different polyadenylation signals).
Alpha isoform: encompasses exons 1,2,3,5-11.
Beta isoform: encompasses exons 1-11.
Gamma isoform: encompasses exons 1,3-11.
Delta isoform: encompasses exons 1,2,5-11.
Epsilon isoform: encompasses exons 1,2,3,6-11.
Zeta isoform: encompasses exons 1,3,5-11.
Eta isoform: encompasses exons 1,5-11.
Alpha, beta, delta, epsilon isoforms can be trans-lated
into functional proteins in vitro; gamma, zeta, eta, are
probably the result of splicing errors.
Pseudogene
None has been described.
Protein
Description
Two isoforms detectable in Western blot of human
placenta and several human cell lines: PTPA alpha, 323
amino acids, 36.8 kDa; PTPA beta, 358 amino acids,
40.7 kDa. pI around 5.8; trypsin-resistant.
Expression
Both isoforms are widely expressed. In a given cell
line, PTPA alpha is about 10x more abundant than
PTPA beta. Very high expression in p53-negative cell
lines (for instance the osteosarcoma cell line Saos-2).
Localisation
Predominantly cytoplasmic.
Atlas Genet Cytogenet Oncol Haematol. 2010; 14(1)
Figure 3. PTPA protein structurePTPA is an all alpha-helical
polypeptide, organized into two domains separated by a
groove. Here the ribbon structure of human PTPA is displayed
(derived from PDB code: 2IXM, Leulliot et al., 2006).
49
PPP2R4 (protein phosphatase 2A activator, regulatory subunit 4)
Janssens V
homologues
from
Drosophila
melanogaster
Saccharomyces
cerevisiae. Biochemistry.
1998
15;37(37):12899-908
Homology
No other human homologues known. Defines a new
family of peptidyl prolyl cis/trans isomerases (PPIases)
with all alpha-helical structure, organized into two
domains separated by a groove.
and
Sep
Janssens V, Van Hoof C, De Baere I, Merlevede W, Goris J.
Functional analysis of the promoter region of the human
phosphotyrosine phosphatase activator gene: Yin Yang 1 is
essential for core promoter activity. Biochem J. 1999 Dec
15;344 Pt 3:755-63
To be noted
Janssens V, Van Hoof C, De Baere I, Merlevede W, Goris J.
The phosphotyrosyl phosphatase activator gene is a novel p53
target gene. J Biol Chem. 2000 Jul 7;275(27):20488-95
Note
Although there is a huge and accumulating literature
implicating PP2A in cancer etiology, PP2A enzymes
represent a large and diverse family of holoenzymes,
and the functional implications of specific complexes
are only beginning to emerge. As such, it is clear that
some PP2A holoenzymes may act as tumor
suppressors, whereas others may on the contrary rather
promote tumorigenesis.
As for PPP2R4, one of the many cellular
regulators/subunits of PP2A, there is as yet no direct
evidence that this gene product is directly involved in
these pathological processes.
Janssens V, van Hoof C, Martens E, de Baere I, Merlevede W,
Goris J. Identification and characterization of alternative splice
products encoded by the human phosphotyrosyl phosphatase
activator gene. Eur J Biochem. 2000 Jul;267(14):4406-13
Rempola B, Kaniak A, Migdalski A, Rytka J, Slonimski PP, di
Rago JP. Functional analysis of RRD1 (YIL153w) and RRD2
(YPL152w), which encode two putative activators of the
phosphotyrosyl
phosphatase
activity
of
PP2A
in
Saccharomyces cerevisiae. Mol Gen Genet. 2000
Jan;262(6):1081-92
Van Hoof C, Janssens V, De Baere I, de Winde JH, Winderickx
J, Dumortier F, Thevelein JM, Merlevede W, Goris J. The
Saccharomyces cerevisiae homologue YPA1 of the
mammalian phosphotyrosyl phosphatase activator of protein
phosphatase 2A controls progression through the G1 phase of
the yeast cell cycle. J Mol Biol. 2000 Sep 8;302(1):103-20
References
Cayla X, Goris J, Hermann J, Hendrix P, Ozon R, Merlevede
W. Isolation and characterization of a tyrosyl phosphatase
activator from rabbit skeletal muscle and Xenopus laevis
oocytes. Biochemistry. 1990 Jan 23;29(3):658-67
Janssens V, Goris J. Protein phosphatase 2A: a highly
regulated family of serine/threonine phosphatases implicated in
cell growth and signalling. Biochem J. 2001 Feb 1;353(Pt
3):417-39
Cayla X, Van Hoof C, Bosch M, Waelkens E, Vandekerckhove
J, Peeters B, Merlevede W, Goris J. Molecular cloning,
expression, and characterization of PTPA, a protein that
activates the tyrosyl phosphatase activity of protein
phosphatase 2A. J Biol Chem. 1994 Jun 3;269(22):15668-75
Mitchell DA, Sprague GF Jr. The phosphotyrosyl phosphatase
activator, Ncs1p (Rrd1p), functions with Cla4p to regulate the
G(2)/M transition in Saccharomyces cerevisiae. Mol Cell Biol.
2001 Jan;21(2):488-500
Van Hoof C, Cayla X, Bosch M, Merlevede W, Goris J. The
phosphotyrosyl phosphatase activator of protein phosphatase
2A. A novel purification method, immunological and enzymic
characterization. Eur J Biochem. 1994 Dec 15;226(3):899-907
Rempola B, Kaniak A, di Rago JP, Rytka J. Anaerobic growth
of Saccharomyces cerevisiae alleviates the lethal effect of
phosphotyrosyl phosphatase activators depletion. Acta
Biochim Pol. 2001;48(4):1043-9
Van Hoof C, Aly MS, Garcia A, Cayla X, Cassiman JJ,
Merlevede W, Goris J. Structure and chromosomal localization
of the human gene of the phosphotyrosyl phosphatase
activator (PTPA) of protein phosphatase 2A. Genomics. 1995
Jul 20;28(2):261-72
Van Hoof C, Janssens V, De Baere I, Stark MJ, de Winde JH,
Winderickx J, Thevelein JM, Merlevede W, Goris J. The
Saccharomyces cerevisiae phosphotyrosyl phosphatase
activator proteins are required for a subset of the functions
disrupted by protein phosphatase 2A mutations. Exp Cell Res.
2001 Apr 1;264(2):372-87
Agostinis P, Donella-Deana A, Van Hoof C, Cesaro L, Brunati
AM, Ruzzene M, Merlevede W, Pinna LA, Goris J. A
comparative study of the phosphotyrosyl phosphatase
specificity of protein phosphatase type 2A and phosphotyrosyl
phosphatase type 1B using phosphopeptides and the
phosphoproteins p50/HS1, c-Fgr and Lyn. Eur J Biochem.
1996 Mar 1;236(2):548-57
Fellner T, Lackner DH, Hombauer H, Piribauer P, Mudrak I,
Zaragoza K, Juno C, Ogris E. A novel and essential
mechanism determining specificity and activity of protein
phosphatase 2A (PP2A) in vivo. Genes Dev. 2003 Sep
1;17(17):2138-50
Longin S, Jordens J, Martens E, Stevens I, Janssens V,
Rondelez E, De Baere I, Derua R, Waelkens E, Goris J, Van
Hoof C. An inactive protein phosphatase 2A population is
associated with methylesterase and can be re-activated by the
phosphotyrosyl phosphatase activator. Biochem J. 2004 May
15;380(Pt 1):111-9
Janssens V, Van Hoof C, Merlevede W, Goris J. PTPA
regulating PP2A as a dual specificity phosphatase. Methods
Mol Biol. 1998;93:103-15
Ramotar D, Belanger E, Brodeur I, Masson JY, Drobetsky EA.
A yeast homologue of the human phosphotyrosyl phosphatase
activator PTPA is implicated in protection against oxidative
DNA damage induced by the model carcinogen 4nitroquinoline
1-oxide.
J
Biol
Chem.
1998
Aug
21;273(34):21489-96
MacKeigan JP, Murphy LO, Blenis J. Sensitized RNAi screen
of human kinases and phosphatases identifies new regulators
of apoptosis and chemoresistance. Nat Cell Biol. 2005
Jun;7(6):591-600
Van Hoof C, Janssens V, Dinishiotu A, Merlevede W, Goris J.
Functional analysis of conserved domains in the
phosphotyrosyl phosphatase activator. Molecular cloning of the
Atlas Genet Cytogenet Oncol Haematol. 2010; 14(1)
Van Hoof C, Martens E, Longin S, Jordens J, Stevens I,
Janssens V, Goris J. Specific interactions of PP2A and PP2Alike phosphatases with the yeast PTPA homologues, Ypa1 and
Ypa2. Biochem J. 2005 Feb 15;386(Pt 1):93-102
50
PPP2R4 (protein phosphatase 2A activator, regulatory subunit 4)
Janssens V
Zheng Y, Jiang Y. The yeast phosphotyrosyl phosphatase
activator is part of the Tap42-phosphatase complexes. Mol Biol
Cell. 2005 Apr;16(4):2119-27
P. The crystal structure of a human PP2A phosphatase
activator reveals a novel fold and highly conserved cleft
implicated in protein-protein interactions. J Biol Chem. 2006
Aug 11;281(32):22434-8
Chao Y, Xing Y, Chen Y, Xu Y, Lin Z, Li Z, Jeffrey PD, Stock
JB, Shi Y. Structure and mechanism of the phosphotyrosyl
phosphatase activator. Mol Cell. 2006 Aug;23(4):535-46
Azam S, Drobetsky E, Ramotar D. Overexpression of the
cis/trans isomerase PTPA triggers caspase 3-dependent
apoptosis. Apoptosis. 2007 Jul;12(7):1243-55
Jordens J, Janssens V, Longin S, Stevens I, Martens E,
Bultynck G, Engelborghs Y, Lescrinier E, Waelkens E, Goris J,
Van Hoof C. The protein phosphatase 2A phosphatase
activator is a novel peptidyl-prolyl cis/trans-isomerase. J Biol
Chem. 2006 Mar 10;281(10):6349-57
Hombauer H, Weismann D, Mudrak I, Stanzel C, Fellner T,
Lackner DH, Ogris E. Generation of active protein
phosphatase 2A is coupled to holoenzyme assembly. PLoS
Biol. 2007 Jun;5(6):e155
Leulliot N, Vicentini G, Jordens J, Quevillon-Cheruel S, Schiltz
M, Barford D, van Tilbeurgh H, Goris J. Crystal structure of the
PP2A phosphatase activator: implications for its PP2A-specific
PPIase activity. Mol Cell. 2006 Aug 4;23(3):413-24
This article should be referenced as such:
Janssens V. PPP2R4 (protein phosphatase 2A activator,
regulatory subunit 4). Atlas Genet Cytogenet Oncol Haematol.
2010; 14(1):48-51.
Magnusdottir A, Stenmark P, Flodin S, Nyman T,
Hammarström M, Ehn M, Bakali H MA, Berglund H, Nordlund
Atlas Genet Cytogenet Oncol Haematol. 2010; 14(1)
51